ClinicalMetric / Countries / Sweden / prostate cancer
← 🇸🇪 Sweden Trials
🇸🇪 Sweden Country × Condition

prostate cancer Clinical Trials in Sweden

Active clinical trials for prostate cancer with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 4 // Recruiting: 4 Phases: Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇸🇪 Sweden

Active Trials in Sweden (4)

NCT06363435
Recruiting

AI-based Measurements of Tumour Burden in PSMA PET-CT

Enrollment
1,500 pts
Country
🇸🇪 Sweden
Elin Tragardh
View Trial →
NCT06719206
Recruiting

Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study

Enrollment
172 pts
Country
🇸🇪 Sweden
Mälardalen University
View Trial →
NCT06449664
Recruiting

Training for Men Undergoing Androgen Deprivation Therapy.

Enrollment
60 pts
Country
🇸🇪 Sweden
The Swedish School of Sport and Hea...
View Trial →
NCT06474806 Phase 2
Recruiting

Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer

Enrollment
168 pts
Country
🇸🇪 Sweden
Curasight
View Trial →

Frequently Asked Questions

How many prostate cancer clinical trials are active in Sweden?
There are currently 4 active clinical trials for prostate cancer with sites in Sweden, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in Sweden?
To join a prostate cancer clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in Sweden?
Active prostate cancer trials in Sweden span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Sweden Trials → Global prostate cancer Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology